Skip to content

Clinical trials

Hearing Loss trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hearing Loss Phase: Not applicable Country / region: United States Clear all

204 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20051
20062
20075
20082
20094
20103
20112
20126
20138
20148
20158
20168
20176
201810
20198
20209
202125
202218
202325
202415
202513
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed115
Recruiting36
Terminated12
Not yet recruiting10
Unknown status9
Enrolling by invitation8
Active, not recruiting7
Withdrawn6
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sonova AG21
VA Office of Research and Development13
Cochlear12
NYU Langone Health9
Northwestern University7
University of North Carolina, Chapel Hill6
Johns Hopkins University5
University of California, San Francisco5
Washington University School of Medicine5
Advanced Bionics4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hearing Loss204
Hearing Loss, Sensorineural18
Deafness15
Hearing Disorders8
Presbycusis8
Hearing Loss, Bilateral6
Ear Diseases5
Otorhinolaryngologic Diseases5
Alzheimer Disease4
Cognitive Dysfunction4

Trials

Showing 1 to 25 of 204. Each trial links to its page on Pharma Observatory.

104 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.